Metformin and Diammonium Glycyrrhizinate Enteric-Coated Capsule versus Metformin Alone versus Diammonium Glycyrrhizinate Enteric-Coated Capsule Alone in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

Figure 2

Changes in liver enzymes and lipid parameters over the 24-week treatment period (histogram). refer to for comparisons within metformin group. refer to for comparisons within DGEC group. refer to for comparisons within drug combination group. refers to for comparisons within metformin group. refer to for comparisons within DGEC group. + refer to for comparisons within DGEC group.